- Report
- August 2024
- 193 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- September 2024
- 288 Pages
Global
From €3818EUR$4,000USD£3,199GBP
- Report
- February 2025
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Newsletter
- March 2025
Global
€2858EUR$2,995USD£2,395GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3102EUR$3,250USD£2,599GBP
- Report
- August 2022
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2022
- 113 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- July 2022
- 65 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- May 2022
- 56 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2022
- 41 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Book
- October 2022
- 448 Pages
- Book
- March 2015
- 512 Pages
- Book
- August 2011
- 466 Pages
- Book
- October 2022
- 448 Pages
- Book
- May 2022
- 560 Pages
- Book
- October 2021
- 272 Pages
- Book
- August 2019
- 1024 Pages

The Nitric Oxide market within the context of Biotechnology is a rapidly growing sector. Nitric Oxide (NO) is a gas molecule that plays a key role in many biological processes, including cell signaling, inflammation, and vascular homeostasis. NO is produced endogenously by nitric oxide synthase (NOS) enzymes, and can also be generated exogenously through the use of NO donors. NO donors are used in a variety of biotechnological applications, such as drug delivery, gene therapy, and tissue engineering.
The NO market is driven by the increasing demand for NO-based therapies, as well as the development of new NO-based technologies. The market is also supported by the growing number of clinical trials and research studies that are exploring the potential of NO-based therapies.
Some companies in the Nitric Oxide market include NOXXON Pharma, NOX Therapeutics, and NOX Biotech. These companies are focused on developing NO-based therapies and technologies for a variety of medical applications. Show Less Read more